SCHEMBL29925217

SCHEMBL29925217

C=Cc1ccc(C(=O)NC)cc1F

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 3/20 0.45
THRB P10828 1/20 0.45
HDAC6 Q9UBN7 5/20 0.44
HDAC1 Q13547 3/20 0.44
HDAC8 Q9BY41 2/20 0.43
HDAC2 Q92769 1/20 0.43
ACSS2 Q9NR19 2/20 0.41
PLAU P00749 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
IP6K1 Q92551 1/20 0.40
IP6K3 Q96PC2 1/20 0.40
IP6K2 Q9UHH9 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24619371 1.00 PLK1 (0.45) PLK1THRBHDAC6HDAC1HDAC8
SCHEMBL20017813 0.85 PLK1 (0.46) PLK1THRBHDAC6HDAC1HDAC8
SCHEMBL4129101 0.80 CA1 (0.47) SMN1; SMN2HPGDHTTTDP1GAA
SCHEMBL4096586 0.79 LMNA (0.49) TSHRHTTTDP1GAA
SCHEMBL531941 0.78 CES2 (0.59) THRBHDAC6HDAC1HDAC8HDAC2
SCHEMBL30147734 0.78 CES2 (0.59) THRBHDAC6HDAC1HDAC8HDAC2
SCHEMBL30147494 0.75 HDAC6 (0.73) PLK1THRBHDAC6HDAC1HDAC8
SCHEMBL8515075 0.75 ESRRG (0.50) PLK1THRBHDAC6HDAC1HDAC8
SCHEMBL29306646 0.75 GAA (0.58) PLK1THRBHDAC6HDAC1HDAC8
SCHEMBL1441177 0.75 HDAC6 (0.73) PLK1THRBHDAC6HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4274569-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2023-11-15 EP disclosed
WO-2022150316-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2022-07-14 WO disclosed